Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsectors
Peptides
Small molecules
Indications
Endocrine, nutritional and metabolic diseases / endocrinology
Digestive system / gastroenterology
Skin and subcutaneous tissue / dermatology
Musculoskeletal system and connective tissue / Orthopedics
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Products
In development: 12
Description
Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines. The company's product Petrelintide is an investigational long-acting amylin analog for once-weekly subcutaneous administration that has been designed with chemical and physical stability at neutral pH, minimizing fibrillation and allowing for co-formulation with other peptides. The company's other product dapiglutide is an investigational long-acting GLP-1/GLP-2 receptor dual agonist for...
